Archive
Royal Mail profit warning and management changes to overshadow first half results
The day ahead includes first half results from Royal Mail and a third quarter trading update from Bovis Homes
Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 23 of 38
Archive
Proactive news snapshot: Haydale Graphene Industries, Tissue Regenix, to Hurricane Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
BTG shares gain on solid interims while Interserve slumps for second day in a row
A look at the day's gainers and painers, including Vodafone, FirstGroup and Haydale Graphene
Investments and investor services
FTSE 100 flatlines at close as sterling gains on Brexit optimism
The UK blue-chip benchmark closed up 0.68 at 7,053, while the FTSE 250 added over 174 points at 18,985
Growing opportunities in respiratory space could accelerate Circassia’s path to profitability, says analyst
Some of the big boys are shifting their focus away from their respiratory drugs, which could open up opportunities for Circassia to in-license them
Archive
Housebuilders to take centre stage again after Persimmon boss drama
The week ahead includes trading updates from Bovis Homes and Taylor Wimpey, full year results from McCarthy & Stone, interims from Royal Mail, Vodafone and Premier Foods along with a batch of UK data
Hikma and Vectura to develop generic version of GSK’s blockbuster Ellipta inhaler
It is not the first time the pair have targeted Glaxo, they have previously developed a cut-price version of Advair
GSK ups full-year earnings forecasts on strong sales of Shringrix vaccine
The FTSE 100 drugmaker now expects full-year adjusted earnings per share to climb by 8-10% in 2018, while it is also guiding for overall full-year performance at the upper end of previous expectations
Investments and investor services
FTSE 100 closes firmly ahead as it puts dismal October to rest
The FTSE 100 closed up around 92 points at 7,182. FTSE 250 also gained..
GlaxoSmithKline releases upbeat injectable HIV treatment results
Trials for ViiV Healthcare's once-a-month injection show it is as effective as the current standard of care for HIV patients
Archive
Glaxo getting the tingles from its shingles jab
Trading updates from Glaxo, Standard Chartered and Next are likely to be the highlights
Archive
UK Budget, BoE, US jobs data to sandwich flood of corporate updates from likes of BP and Shell
Aside from the oil majors, the slew of blue-chip updates due in the coming week will include global banks HSBC and Standard Chartered, and drugs firms GlaxoSmithKlne and Shire
Investments and investor services
FTSE 100 closes down nearly 2% as the big sell-off continues
The UK blue-chip benchmark finished down nearly 139 points lower at 7,006 - not far from the 7,000 mark
Archive
Hays to receive boost from German operations
Solid results from sector peer PageGroup should give Hays shareholders cause to feel optimistic
Archive
Retailers and recruiters in week ahead spotlight with results from N Brown, WH Smith, PageGroup and Hays
The week ahead sees updates from N Brown, WH Smith, Hays, PageGroup, Greggs, RPC Group and Marston's
FTSE 100 closes higher as US stocks surge
The UK's premier index closed up around 36 points at 7,367.
Investments and investor services
Diageo expected to be the toast of Thursday’s market news
Diageo and Lamprell are expected to be among the names under focus in Thursday's schedule.
New contract wins with UK blue-chips help first-half revenues soar at Be Heard
New business from the likes of Vodafone and GSK and a strong contribution from The Corner, which it acquired in December, meant revenues jumped 70% in the first half
Archive
UK inflation and retail sales data eyed, plus trading updates from Kingfisher and Ocado
Aside from the UK data and the retail updates, the Week Ahead will also bring news from the likes of Diageo, Dairy Crest, Smiths Group, Lamprell, and SIG
Immutep valuation increased 16% to $510 million by Edison Investment Research
The research note puts the value per share at 14 cents each, or 12 cents after dilutions.